FDA recalls Nipros diabetes insulin syringes

The FDA and Nipro Medical have issued a voluntary nationwide recall of all GlucoPro insulin syringes, which may have needles that detach from the syringe.

According to the agency, if the needle becomes detached from the syringe during use, it can become stuck in the insulin vial, push back into the syringe, or remain in the skin after injection. The recall includes all product codes and lot numbers with expiration dates before Nov. 1, 2011. The product was distributed across the U.S., including Puerto Rico.

Consumers who have GlucoPro Insulin Syringes should stop using them and return them to point of sale for reimbursement, according to the FDA notice.

The Miami-based company said this recall does not include the GlucoPro syringe specific for use with the Amigo Insulin pump. Also, GlucoPro said that no injuries have been reported to date.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.